Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Targeting regulatory T cells may help treat age-related diseases.

Autoimmune skin diseases result from genetic and environmental factors disrupting immune checkpoints.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

JAK inhibitors might help treat alopecia areata.

IL-17-producing γδ T cells help improve bone healing.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Innate lymphoid cells help us understand and manage allergic diseases better.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

γδ T cells are essential for wound healing after poxvirus infection.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.